loadpatents
name:-0.018905162811279
name:-0.0091171264648438
name:-0.013394117355347
Navratil; Tomas Patent Filings

Navratil; Tomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Navratil; Tomas.The latest application filed is for "process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions".

Company Profile
7.12.29
  • Navratil; Tomas - Durham NC
  • NAVRATIL; Tomas - Carrboro NC
  • Navratil; Tomas - Morrisville NC
  • NAVRATIL; Tomas - Karlsruhe DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions
Grant 11,406,596 - Bukowski , et al. August 9, 2
2022-08-09
Process For The Preparation Of Sterile Ophthalmic Aqueous Fluticasone Propionate Form A Nanocrystals Suspensions
App 20220241296 - BUKOWSKI; Jean-Michel ;   et al.
2022-08-04
Intracameral Implant For Treatment Of An Ocular Condition
App 20220080049 - Garcia; Andres ;   et al.
2022-03-17
Intravitreal drug delivery systems for the treatment of ocular conditions
Grant 11,116,776 - Williams , et al. September 14, 2
2021-09-14
Adjustment Device
App 20210265923 - NAVRATIL; Tomas
2021-08-26
Glaucoma Treatment Via Intracameral Ocular Implants
App 20210228408 - Navratil; Tomas ;   et al.
2021-07-29
Process For The Preparation Of Sterile Ophthalmic Aqueous Fluticasone Propionate Form A Nanocrystals Suspensions
App 20210023001 - BUKOWSKI; Jean-Michel ;   et al.
2021-01-28
Implant applicators and methods of administering implants
Grant 10,849,656 - Navratil , et al. December 1, 2
2020-12-01
Intravitreal Drug Delivery Systems For The Treatment Of Ocular Conditions
App 20200230157 - Williams; Stuart ;   et al.
2020-07-23
Intravitreal drug delivery systems for the treatment of ocular conditions
Grant 10,624,904 - Williams , et al.
2020-04-21
Aerosol Delivery Systems, Compositions And Methods
App 20200054558 - BOUCHER; Paul ;   et al.
2020-02-20
Implant Applicators
App 20190374380 - Navratil; Tomas ;   et al.
2019-12-12
Methods of treatment
Grant 10,335,558 - Boucher , et al.
2019-07-02
Intravitreal Drug Delivery Systems For The Treatment Of Ocular Conditions
App 20190083512 - Williams; Stuart ;   et al.
2019-03-21
Implant Applicators And Methods Of Administering Implants
App 20180368886 - NAVRATIL; Tomas ;   et al.
2018-12-27
Implant For Treatment Of An Ocular Condition
App 20180177718 - Garcia; Andres ;   et al.
2018-06-28
Intracameral Implant For Treatment Of An Ocular Condition
App 20160296627 - Garcia; Andres ;   et al.
2016-10-13
Aerosol Delivery Systems, Compositions And Methods
App 20150150803 - BOUCHER; Paul ;   et al.
2015-06-04
Methods Of Treatment
App 20150101597 - BOUCHER; Richard C. ;   et al.
2015-04-16
Aerosol delivery systems, compositions and methods
Grant 8,945,605 - Boucher , et al. February 3, 2
2015-02-03
Methods of treatment
Grant 8,778,383 - Boucher , et al. July 15, 2
2014-07-15
Nasal Cannula For Delivery Of Aerosolized Medicaments
App 20140158127 - BOUCHER; Paul ;   et al.
2014-06-12
Aerosol Delivery Systems, Compositions And Methods
App 20140109899 - Boucher; Paul ;   et al.
2014-04-24
Method For Treating Cardiovascular Diseases Using Rho Kinase Inhibitor Compounds
App 20130172324 - LAMPE; John W. ;   et al.
2013-07-04
Method For Treating Diseases Associated With Alterations In Cellular Integrity Using Rho Kinase Inhibitor Compounds
App 20130158014 - PETERSON; Ward M. ;   et al.
2013-06-20
Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds
Grant 8,410,147 - Peterson , et al. April 2, 2
2013-04-02
Methods Of Treatment
App 20130074842 - Boucher; Richard C. ;   et al.
2013-03-28
Method For Treating Pulmonary Diseases Using Rho Kinase Inhibitor Compounds
App 20130005756 - NAVRATIL; Tomas ;   et al.
2013-01-03
Method for treating pulmonary diseases using rho kinase inhibitor compounds
Grant 8,299,096 - Navratil , et al. October 30, 2
2012-10-30
Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds
Grant 8,207,195 - Navratil , et al. June 26, 2
2012-06-26
Method For Treating Inflammatory Conditions
App 20100160250 - Douglass, III; James G. ;   et al.
2010-06-24
Method For Treating Cardiovascular Diseases Using Rho Kinase Inhibitor Compounds
App 20100008968 - Lampe; John W. ;   et al.
2010-01-14
Method For Treating Ophthalmic Diseases Using Rho Kinase Inhibitor Compounds
App 20090325959 - Vittitow; Jason L. ;   et al.
2009-12-31
Method For Treating Neurological And Neuropathic Diseases Using Rho Kinase Inhibitor Compounds
App 20090325934 - Navratil; Tomas ;   et al.
2009-12-31
Method For Treating Inflammatory Diseases Using Rho Kinase Inhibitor Compounds
App 20090325960 - Fulcher; Emilee H. ;   et al.
2009-12-31
Method For Treating Diseases Associated With Alterations In Cellular Integrity Using Rho Kinase Inhibitor Compounds
App 20090325905 - Peterson; Ward M. ;   et al.
2009-12-31
Method For Treating Pulmonary Diseases Using Rho Kinase Inhibitor Compounds
App 20090325958 - Navratil; Tomas ;   et al.
2009-12-31
Method Of Treating Pulmonary Edema Or Pulmonary Inflammation
App 20090098064 - Navratil; Tomas ;   et al.
2009-04-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed